Treatment of osteoarthritis knee pain injection concentrate a patient's own plasma

• Conditions: Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]; Pain?s treatment of the Osteoarthritic Knee

• Registration Number: EUCTR2013-001303-36-ES
• Lead Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-08-14
• Last Update Posted: 10 July 2015

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Arthritis in the knee rated I, II, or III, VAS greater than 5, between 40 and 80 years of age.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 25

Exclusion Criteria

Level IV arthritis of the knee, either surgery, corticoid infiltration, or viscosupplementation in the knee in the previous three months, frontal deformity greater than 10 degrees, ipsilateral pathology of the knee or ankle, range of motion or flexibility of the knee less than 90 degrees, deficit of knee extention greater than 15 degrees, anticoagulation treatment, antiplatement treatment, hepatopathy, hematological or neoplastic pathology, active infection, fibromyalgia, or chronic fatigue syndrome.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified